vs
Laird Superfood, Inc.(LSF)与NeuroPace Inc(NPCE)财务数据对比。点击上方公司名可切换其他公司
NeuroPace Inc的季度营收约是Laird Superfood, Inc.的2.0倍($26.6M vs $13.3M),NeuroPace Inc净利率更高(-10.3% vs -13.2%,领先2.9%),NeuroPace Inc同比增速更快(23.9% vs 15.0%),过去两年NeuroPace Inc的营收复合增速更高(21.1% vs 16.1%)
Laird Superfood是一家主营植物基功能性超级食品的企业,产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等,面向健康意识较强的消费群体,主要在北美市场通过电商及线下零售渠道销售,主打可持续采购的清洁配方。
NeuroPace Inc是一家专注于神经调控技术的医疗科技企业,核心产品为可植入式响应神经刺激系统,主要用于治疗药物难治性癫痫,通过与医疗机构合作,为北美及部分全球市场的患者提供个性化治疗方案,降低癫痫发作频率。
LSF vs NPCE — 直观对比
营收规模更大
NPCE
是对方的2.0倍
$13.3M
营收增速更快
NPCE
高出8.8%
15.0%
净利率更高
NPCE
高出2.9%
-13.2%
两年增速更快
NPCE
近两年复合增速
16.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $13.3M | $26.6M |
| 净利润 | $-1.8M | $-2.7M |
| 毛利率 | 34.1% | 77.4% |
| 营业利润率 | -13.5% | -6.6% |
| 净利率 | -13.2% | -10.3% |
| 营收同比 | 15.0% | 23.9% |
| 净利润同比 | -341.4% | 48.0% |
| 每股收益(稀释后) | — | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LSF
NPCE
| Q4 25 | $13.3M | $26.6M | ||
| Q3 25 | $12.9M | $27.4M | ||
| Q2 25 | $12.0M | $23.5M | ||
| Q1 25 | $11.7M | $22.5M | ||
| Q4 24 | $11.6M | $21.5M | ||
| Q3 24 | $11.8M | $21.1M | ||
| Q2 24 | $10.0M | $19.3M | ||
| Q1 24 | $9.9M | $18.1M |
净利润
LSF
NPCE
| Q4 25 | $-1.8M | $-2.7M | ||
| Q3 25 | $-975.1K | $-3.5M | ||
| Q2 25 | $-362.2K | $-8.7M | ||
| Q1 25 | $-156.2K | $-6.6M | ||
| Q4 24 | $-398.4K | $-5.3M | ||
| Q3 24 | $-166.1K | $-5.5M | ||
| Q2 24 | $-239.1K | $-7.5M | ||
| Q1 24 | $-1.0M | $-8.9M |
毛利率
LSF
NPCE
| Q4 25 | 34.1% | 77.4% | ||
| Q3 25 | 36.5% | 77.4% | ||
| Q2 25 | 39.9% | 77.1% | ||
| Q1 25 | 41.9% | 77.0% | ||
| Q4 24 | 38.6% | 75.4% | ||
| Q3 24 | 43.0% | 73.2% | ||
| Q2 24 | 41.8% | 73.4% | ||
| Q1 24 | 40.0% | 73.6% |
营业利润率
LSF
NPCE
| Q4 25 | -13.5% | -6.6% | ||
| Q3 25 | -7.7% | -9.5% | ||
| Q2 25 | -3.3% | -29.0% | ||
| Q1 25 | -1.9% | -22.9% | ||
| Q4 24 | -4.1% | -17.0% | ||
| Q3 24 | -2.3% | -20.1% | ||
| Q2 24 | -3.4% | -32.4% | ||
| Q1 24 | -11.0% | -41.6% |
净利率
LSF
NPCE
| Q4 25 | -13.2% | -10.3% | ||
| Q3 25 | -7.6% | -12.8% | ||
| Q2 25 | -3.0% | -36.8% | ||
| Q1 25 | -1.3% | -29.3% | ||
| Q4 24 | -3.4% | -24.5% | ||
| Q3 24 | -1.4% | -25.9% | ||
| Q2 24 | -2.4% | -39.0% | ||
| Q1 24 | -10.3% | -49.2% |
每股收益(稀释后)
LSF
NPCE
| Q4 25 | — | $-0.08 | ||
| Q3 25 | — | $-0.11 | ||
| Q2 25 | — | $-0.26 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | — | $-0.16 | ||
| Q3 24 | — | $-0.19 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | — | $-0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $5.1M | $61.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $11.5M | $19.0M |
| 总资产 | $19.2M | $105.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
LSF
NPCE
| Q4 25 | $5.1M | $61.1M | ||
| Q3 25 | $5.1M | $60.0M | ||
| Q2 25 | $3.9M | $62.1M | ||
| Q1 25 | $7.0M | $66.3M | ||
| Q4 24 | $8.3M | $52.8M | ||
| Q3 24 | $7.9M | $56.8M | ||
| Q2 24 | $7.6M | $55.5M | ||
| Q1 24 | $7.1M | $58.9M |
股东权益
LSF
NPCE
| Q4 25 | $11.5M | $19.0M | ||
| Q3 25 | $12.8M | $18.5M | ||
| Q2 25 | $13.4M | $19.4M | ||
| Q1 25 | $13.3M | $24.3M | ||
| Q4 24 | $13.2M | $8.0M | ||
| Q3 24 | $13.1M | $9.8M | ||
| Q2 24 | $12.6M | $9.9M | ||
| Q1 24 | $12.7M | $14.3M |
总资产
LSF
NPCE
| Q4 25 | $19.2M | $105.6M | ||
| Q3 25 | $18.9M | $107.3M | ||
| Q2 25 | $20.4M | $106.1M | ||
| Q1 25 | $21.5M | $110.2M | ||
| Q4 24 | $19.3M | $94.6M | ||
| Q3 24 | $18.8M | $96.3M | ||
| Q2 24 | $18.0M | $94.4M | ||
| Q1 24 | $17.6M | $98.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $68.4K | $506.0K |
| 自由现金流经营现金流 - 资本支出 | — | $409.0K |
| 自由现金流率自由现金流/营收 | — | 1.5% |
| 资本支出强度资本支出/营收 | — | 0.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-11.3M |
8季度趋势,按日历期对齐
经营现金流
LSF
NPCE
| Q4 25 | $68.4K | $506.0K | ||
| Q3 25 | $1.2M | $-1.9M | ||
| Q2 25 | $-2.8M | $-2.1M | ||
| Q1 25 | $-1.3M | $-7.5M | ||
| Q4 24 | $339.2K | $-4.8M | ||
| Q3 24 | $305.8K | $-1.7M | ||
| Q2 24 | $642.7K | $-3.9M | ||
| Q1 24 | $-422.3K | $-7.5M |
自由现金流
LSF
NPCE
| Q4 25 | — | $409.0K | ||
| Q3 25 | — | $-2.0M | ||
| Q2 25 | — | $-2.3M | ||
| Q1 25 | — | $-7.5M | ||
| Q4 24 | — | $-4.8M | ||
| Q3 24 | — | $-1.8M | ||
| Q2 24 | — | $-4.0M | ||
| Q1 24 | — | $-7.6M |
自由现金流率
LSF
NPCE
| Q4 25 | — | 1.5% | ||
| Q3 25 | — | -7.2% | ||
| Q2 25 | — | -9.6% | ||
| Q1 25 | — | -33.4% | ||
| Q4 24 | — | -22.5% | ||
| Q3 24 | — | -8.7% | ||
| Q2 24 | — | -20.6% | ||
| Q1 24 | — | -42.1% |
资本支出强度
LSF
NPCE
| Q4 25 | — | 0.4% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
NPCE
暂无分部数据